{
  "id": "sunny-balwani",
  "title": "Sunny Balwani",
  "lang": "en",
  "source_lang": "en",
  "summary": "Sunny Balwani is a former Theranos executive convicted in 2022 of conspiracy and wire fraud involving the company’s investors and patients.",
  "category": "economics",
  "subcategory": "business",
  "type": "person",
  "aliases": [
    "Ramesh Balwani",
    "Ramesh “Sunny” Balwani"
  ],
  "generated_at": "2026-11-04",
  "model": "pro/gpt-6.1-sol",
  "url": "https://aiwiki.page/en/sunny-balwani/",
  "translations": {
    "zh-Hans": {
      "url": "https://aiwiki.page/zh/sunny-balwani/",
      "json": "https://aiwiki.page/zh/sunny-balwani.json"
    }
  },
  "sections": [
    {
      "heading": "",
      "text": "Ramesh “Sunny” Balwani is a former business executive who served as president and chief operating officer of Theranos, a company that claimed it could perform a wide range of laboratory tests using very small blood samples. He worked alongside the company’s founder and chief executive, Elizabeth Holmes. In July 2022, a United States federal jury convicted him on all 12 counts of conspiracy and wire fraud brought against him in connection with schemes to defraud Theranos investors and patients. He was subsequently sentenced to 155 months in federal prison."
    },
    {
      "heading": "Business career and Theranos",
      "text": "Before joining Theranos, Balwani worked in the software industry and was involved with CommerceBid, an electronic commerce software business acquired by Commerce One in 1999.\n\nBalwani joined Theranos in 2009 and served as its president and chief operating officer until 2016. He also provided financial support to the company. His responsibilities included operational management and oversight of its laboratory business. Balwani and Holmes were romantically involved during much of his association with Theranos; that relationship was not publicly disclosed while they were leading the company.\n\nTheranos promoted technology that it said could make blood testing faster, cheaper, and more convenient. Its commercial expansion included a partnership with Walgreens to offer testing services through retail locations. However, the company’s proprietary devices could not perform the broad range of tests it advertised, and Theranos used conventional laboratory analyzers for many tests."
    },
    {
      "heading": "Investigations and civil proceedings",
      "text": "Public scrutiny intensified after investigative reporting in 2015 questioned the capabilities of Theranos’s technology and its laboratory practices. Regulatory investigations and the loss of commercial partnerships followed. Theranos dissolved in 2018.\n\nIn March 2018, the U.S. Securities and Exchange Commission brought civil fraud charges against Theranos, Holmes, and Balwani over statements made to investors about the company’s technology, business, and financial performance. Holmes and Theranos reached settlements at that time; Balwani did not join those settlements and contested the allegations.\n\nThe civil enforcement action was separate from the federal criminal prosecution that followed."
    },
    {
      "heading": "Criminal trial and sentence",
      "text": "Federal prosecutors charged Balwani and Holmes in June 2018. Their cases were eventually tried separately.\n\nBalwani’s trial took place in the United States District Court for the Northern District of California. Prosecutors presented evidence concerning misleading representations to investors and the provision of unreliable blood-testing services to patients. Balwani pleaded not guilty, and his defense disputed that he knowingly participated in fraud.\n\nOn July 7, 2022, the jury found him guilty of two counts of conspiracy to commit wire fraud and ten counts of wire fraud. The verdict covered both the investor-related and patient-related schemes.\n\nOn December 7, 2022, the court sentenced Balwani to 155 months—12 years and 11 months—in prison, followed by three years of supervised release. In a subsequent restitution order in 2023, Balwani and Holmes were held jointly and severally liable for approximately $452 million. Joint and several liability means that each is legally responsible for the restitution obligation, rather than the amount being divided into separate equal shares."
    }
  ],
  "links": [
    "theranos",
    "elizabeth-holmes",
    "wire-fraud",
    "e-commerce",
    "securities-and-exchange-commission"
  ],
  "sources": [],
  "license": "https://creativecommons.org/licenses/by/4.0/"
}